Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, Bedrocan Canada, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Medicinals & botanicals
Sub-IndustryCannabis
SectorMedical
Current SymbolNYSE:CGC
Previous Symbol
CUSIPN/A
Phone855-558-9333
Debt
Debt-to-Equity Ratio0.50
Current Ratio6.84
Quick Ratio5.53
Price-To-Earnings
Trailing P/E Ratio-100.50
Forward P/E Ratio-78.44
P/E GrowthN/A
Sales & Book Value
Annual Sales$60.79 million
Price / Sales122.82
Cash FlowN/A
Price / CashN/A
Book Value$4.87 per share
Price / Book6.60
Profitability
EPS (Most Recent Fiscal Year)($0.32)
Net Income$-54,880,000.00
Net Margins-503.14%
Return on Equity-29.97%
Return on Assets-22.53%
Miscellaneous
Employees1,033
Outstanding Shares232,160,000
Market Cap$8.17 billion
OptionableOptionable
Canopy Growth (NYSE:CGC) Frequently Asked Questions
What is Canopy Growth's stock symbol?
Canopy Growth trades on the New York Stock Exchange (NYSE) under the ticker symbol "CGC."
How were Canopy Growth's earnings last quarter?
Canopy Growth Corp (NYSE:CGC) released its earnings results on Wednesday, November, 14th. The marijuana producer reported ($0.76) EPS for the quarter, missing analysts' consensus estimates of ($0.12) by $0.64. The marijuana producer earned $23.30 million during the quarter, compared to analyst estimates of $59.10 million. Canopy Growth had a negative return on equity of 29.97% and a negative net margin of 503.14%. The company's revenue was up 32.4% on a year-over-year basis. View Canopy Growth's Earnings History.
When is Canopy Growth's next earnings date?
What price target have analysts set for CGC?
4 analysts have issued 12 month price objectives for Canopy Growth's stock. Their forecasts range from $19.00 to $61.00. On average, they expect Canopy Growth's stock price to reach $36.6667 in the next year. This suggests a possible upside of 14.0% from the stock's current price. View Analyst Price Targets for Canopy Growth.
What is the consensus analysts' recommendation for Canopy Growth?
4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Canopy Growth in the last year. There are currently 1 sell rating, 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Canopy Growth.
Has Canopy Growth been receiving favorable news coverage?
Media coverage about CGC stock has trended positive this week, according to InfoTrie Sentiment. InfoTrie identifies positive and negative news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Canopy Growth earned a coverage optimism score of 2.8 on InfoTrie's scale. They also gave news stories about the marijuana producer a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the next few days.
Who are some of Canopy Growth's key competitors?
Some companies that are related to Canopy Growth include Actelion (ALIOF), Tilray (TLRY), STADA Arzneimittel (STDAF), USANA Health Sciences (USNA), Cronos Group (CRON), Foamix Pharmaceuticals (FOMX), Chromadex (CDXC), Mediwound (MDWD), Natural Alternatives International (NAII), China Jo-Jo Drugstores (CJJD), Pharmacyte Biotech (PMCB), Mannatech (MTEX), GLG Life Tech (GLGLF), Cyanotech (CYAN) and FitLife Brands (FTLF).
Who are Canopy Growth's key executives?
Canopy Growth's management team includes the folowing people:
- Mr. Bruce A. Linton, Co-Founder, Chairman & Co-CEO
- Mr. Mark Anthony Nicholas Zekulin, Pres & Co-CEO
- Mr. Timothy Rob Saunders, Exec. VP & CFO
- Mr. Rade Kovacevic, Sr. VP & MD
- Mr. Ru Wadasinghe, Chief Information Officer
Who are Canopy Growth's major shareholders?
Canopy Growth's stock is owned by many different of institutional and retail investors. Top institutional investors include Connor Clark & Lunn Investment Management Ltd. (0.78%), Macquarie Group Ltd. (0.59%), TD Asset Management Inc. (0.33%), Artemis Investment Management LLP (0.18%), Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp (0.15%) and QCI Asset Management Inc. NY (0.14%).
Which institutional investors are selling Canopy Growth stock?
CGC stock was sold by a variety of institutional investors in the last quarter, including QCI Asset Management Inc. NY, The Manufacturers Life Insurance Company , CIBC World Markets Inc., Toronto Dominion Bank, Man Group plc, Seven Eight Capital LP, Legal & General Group Plc and First Republic Investment Management Inc..
Which institutional investors are buying Canopy Growth stock?
CGC stock was bought by a variety of institutional investors in the last quarter, including Macquarie Group Ltd., Connor Clark & Lunn Investment Management Ltd., Artemis Investment Management LLP, Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp, Essex Investment Management Co. LLC, FIL Ltd, Mackenzie Financial Corp and Renaissance Technologies LLC.
How do I buy shares of Canopy Growth?
Shares of CGC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Canopy Growth's stock price today?
One share of CGC stock can currently be purchased for approximately $32.16.
How big of a company is Canopy Growth?
Canopy Growth has a market capitalization of $8.17 billion and generates $60.79 million in revenue each year. The marijuana producer earns $-54,880,000.00 in net income (profit) each year or ($0.32) on an earnings per share basis. Canopy Growth employs 1,033 workers across the globe.
What is Canopy Growth's official website?
How can I contact Canopy Growth?
Canopy Growth's mailing address is 1 HERSHEY DRIVE, SMITH FALLS A6, K7A0A8. The marijuana producer can be reached via phone at 855-558-9333 or via email at [email protected]
MarketBeat Community Rating for Canopy Growth (NYSE CGC)
MarketBeat's community ratings are surveys of what our community members think about Canopy Growth and other stocks. Vote "Outperform" if you believe CGC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CGC will underperform the S&P 500 over the long term. You may vote once every thirty days.
